Fundraising FoxOrPro Therapeutics
San Diego, US · Delaware corporation
Find your way into OrPro Therapeutics
Sign up to see every warm intro you have to OrPro Therapeutics
- Paths you didn't know you had: your email and LinkedIn already hold routes to the OrPro Therapeutics team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
OrPro Therapeutics develops non-systemic biologic drugs for diseases of the lung and other epithelial surfaces marked by chronic infection, inflammation, and obstructive mucus, including cystic fibrosis and severe COVID-19. The company works in the biotech and drug development sector.
Founders & leadership
CL
Cam L. GarnerNamed on SEC filing
PB
Peter B. Heifetz, Ph.D.Named on SEC filing
Board
MJ
Mary Jacqueline JohnsonBoard director
JW
Jeffrey W. RaserBoard director
JW
James WeilBoard director
Reported raises · per SEC filings
Form D private placements$2.3M disclosed across 1 round · 2013
▶$2.3MraisedFeb 2016 · 22 investors · BiotechnologyRule 506(b)
▶$2.3MraisedFeb 2016 · 22 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Mary Jacqueline JohnsonDirector
- Cam L. GarnerExecutive Officer, Director
- Jeffrey W. RaserDirector
- James WeilDirector
- Peter B. Heifetz, Ph.D.Executive Officer, Director
- Amount sold
- $2.3M
- First sale
- Dec 2013
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Related companies · 2
MedscapeMedscape is an online platform providing medical news, clinical information, and continuing education resources to physicians and healthcare professionals globally. The platform offers CME courses, drug and disease information, and patient education across multiple specialties.
InduProInduPro develops next-generation protein therapeutics by leveraging inherent and induced proximity to modulate disease biology, with a focus on ADCs and T-cell engagers. The company built proprietary platforms — Membrane Interactomics (MInt) for target discovery, ARRIS for proximity modalities using multi-specific antibody technology, and internal antibody discovery and engineering — to identify targets and design therapeutic molecules.
Companies working in the same space as OrPro Therapeutics.
In the news
Frequently asked questions
- What does OrPro Therapeutics do?
- OrPro Therapeutics develops non-systemic biologic drugs for diseases of the lung and other epithelial surfaces marked by chronic infection, inflammation, and obstructive mucus, including cystic fibrosis and severe COVID-19. The company works in the biotech and drug development sector.
- How much funding has OrPro Therapeutics raised?
- OrPro Therapeutics has disclosed $2.3M raised across 1 round.
- Where is OrPro Therapeutics headquartered?
- OrPro Therapeutics is headquartered in San Diego, US.